CCGA Workgroup: Difference between revisions
No edit summary |
No edit summary |
||
| (5 intermediate revisions by the same user not shown) | |||
| Line 110: | Line 110: | ||
|Thurston | |Thurston | ||
|Atrium Health | |Atrium Health | ||
|- | |- | ||
|Jennifer | |Jennifer | ||
| Line 170: | Line 166: | ||
|Nguyen | |Nguyen | ||
|GeneDx | |GeneDx | ||
|- | |||
|Jieying | |||
|Chu | |||
|NeoGenomics Laboratories | |||
|- | |||
|Hannah | |||
|Wollenzien | |||
|Sanford Health | |||
|- | |||
|He | |||
|Fang | |||
|University of Washington | |||
|- | |||
|Wenying (Layla) | |||
|Zhu | |||
|University of Melbourne | |||
|- | |||
|Pallavi | |||
|Khattar | |||
|Zucker SOM at Hofstra/ Northwell Health | |||
|} | |} | ||